'Vaccine Shortage' in India, Purchase Negotiations with Pfizer and J&J

[Image source=AP Yonhap News]

[Asia Economy Reporter Jeon Jinyoung] India, which has experienced a vaccine shortage crisis, is currently negotiating with Western pharmaceutical companies to import vaccines.

According to the Wall Street Journal (WSJ) on the 11th (local time), the Indian government is currently negotiating to purchase 50 million doses of vaccines from Pfizer. It is also known to be in talks with Johnson & Johnson. The vaccine developed by Janssen, a subsidiary of Johnson & Johnson, was granted emergency use authorization in India on the 7th.

India is also scheduled to receive 7 million doses of the Moderna vaccine from the United States through the international vaccine-sharing project COVAX.

India is the largest producer, manufacturing 60% of the world's vaccines, but is facing a vaccine shortage crisis. It is pointed out that domestic production has been sluggish due to unresolved raw material shortages, and that pricing and procurement policies were also inadequate.

This content was produced with the assistance of AI translation services.